Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
discussions, stats, and author profiles for this publication at: https://www.researchgate.net/publication/281820779
CITATIONS READS
2 280
8 authors, including:
Joo-Sang Lee
Catholic University of Daegu
17 PUBLICATIONS 82 CITATIONS
SEE PROFILE
Some of the authors of this publication are also working on these related projects:
All content following this page was uploaded by Hung Tran Manh on 21 September 2015.
EDITORS
ADVISORY BOARD
PROFESSOR ALEJANDRO F. BARRERO
Department of Organic Chemistry, Prof. Viqar Uddin Ahmad Prof. Niel A. Koorbanally
University of Granada, Karachi, Pakistan Durban, South Africa
Campus de Fuente Nueva, s/n, 18071, Granada, Spain
Prof. Giovanni Appendino Prof. Chiaki Kuroda
afbarre@ugr.es
Novara, Italy Tokyo, Japan
PROFESSOR ALESSANDRA BRACA
Dipartimento di Chimica Bioorganicae Biofarmacia, Prof. Yoshinori Asakawa Prof. Hartmut Laatsch
Universita di Pisa, Tokushima, Japan Gottingen, Germany
via Bonanno 33, 56126 Pisa, Italy Prof. Roberto G. S. Berlinck Prof. Marie Lacaille-Dubois
braca@farm.unipi.it São Carlos, Brazil Dijon, France
PROFESSOR DE-AN GUO Prof. Anna R. Bilia Prof. Shoei-Sheng Lee
State Key Laboratory of Natural and Biomimetic Drugs, Taipei, Taiwan
Florence, Italy
School of Pharmaceutical Sciences,
Peking University, Prof. Maurizio Bruno Prof. Imre Mathe
Beijing 100083, China Palermo, Italy Szeged, Hungary
gda5958@163.com Prof. César A. N. Catalán Prof. M. Soledade C. Pedras
PROFESSOR YOSHIHIRO MIMAKI Tucumán, Argentina Saskatoon, Canada
School of Pharmacy, Prof. Josep Coll Prof. Luc Pieters
Tokyo University of Pharmacy and Life Sciences, Barcelona, Spain Antwerp, Belgium
Horinouchi 1432-1, Hachioji, Tokyo 192-0392, Japan
mimakiy@ps.toyaku.ac.jp Prof. Geoffrey Cordell Prof. Peter Proksch
Chicago, IL, USA Düsseldorf, Germany
PROFESSOR STEPHEN G. PYNE
Department of Chemistry Prof. Fatih Demirci Prof. Phila Raharivelomanana
University of Wollongong Eskişehir, Turkey Tahiti, French Polynesia
Wollongong, New South Wales, 2522, Australia Prof. Ana Cristina Figueiredo Prof. Luca Rastrelli
spyne@uow.edu.au Lisbon, Portugal Fisciano, Italy
PROFESSOR MANFRED G. REINECKE Prof. Cristina Gracia-Viguera Prof. Stefano Serra
Department of Chemistry, Milano, Italy
Murcia, Spain
Texas Christian University,
Forts Worth, TX 76129, USA Dr. Christopher Gray Prof. Monique Simmonds
m.reinecke@tcu.edu Saint John, NB, Canada Richmond, UK
PROFESSOR WILLIAM N. SETZER Prof. Dominique Guillaume Dr. Bikram Singh
Department of Chemistry Reims, France Palampur, India
The University of Alabama in Huntsville Prof. John L. Sorensen
Prof. Duvvuru Gunasekar
Huntsville, AL 35809, USA
Tirupati, India Manitoba, Canada
wsetzer@chemistry.uah.edu
PROFESSOR YASUHIRO TEZUKA Prof. Hisahiro Hagiwara Prof. Johannes van Staden
Faculty of Pharmaceutical Sciences Niigata, Japan Scottsville, South Africa
Hokuriku University Prof. Tsukasa Iwashina Prof. Valentin Stonik
Ho-3 Kanagawa-machi, Kanazawa 920-1181, Japan Tsukuba, Japan Vladivostok, Russia
y-tezuka@hokuriku-u.ac.jp
Prof. Leopold Jirovetz Prof. Winston F. Tinto
PROFESSOR DAVID E. THURSTON Vienna, Austria Barbados, West Indies
Department of Pharmacy and Forensic Science,
King’s College London, Prof. Vladimir I Kalinin Prof. Sylvia Urban
Britannia House, 7 Trinity Street, Vladivostok, Russia Melbourne, Australia
London SE1 1DB, UK. Prof. Phan Van Kiem Prof. Karen Valant-Vetschera
david.thurston@kcl.ac.uk Hanoi, Vietnam Vienna, Austria
Full details of how to submit a manuscript for publication in Natural Product Communications are given in Information for Authors on our Web site
http://www.naturalproduct.us.
Authors may reproduce/republish portions of their published contribution without seeking permission from NPC, provided that any such republication is
accompanied by an acknowledgment (original citation)-Reproduced by permission of Natural Product Communications. Any unauthorized reproduction,
transmission or storage may result in either civil or criminal liability.
The publication of each of the articles contained herein is protected by copyright. Except as allowed under national “fair use” laws, copying is not permitted by
any means or for any purpose, such as for distribution to any third party (whether by sale, loan, gift, or otherwise); as agent (express or implied) of any third
party; for purposes of advertising or promotion; or to create collective or derivative works. Such permission requests, or other inquiries, should be addressed
to the Natural Product Inc. (NPI). A photocopy license is available from the NPI for institutional subscribers that need to make multiple copies of single
articles for internal study or research purposes.
To Subscribe: Natural Product Communications is a journal published monthly. 2015 subscription price: US$2,595 (Print, ISSN# 1934-578X); US$2,595
(Web edition, ISSN# 1555-9475); US$2,995 (Print + single site online); US$595 (Personal online). Orders should be addressed to Subscription Department,
Natural Product Communications, Natural Product Inc., 7963 Anderson Park Lane, Westerville, Ohio 43081, USA. Subscriptions are renewed on an annual
basis. Claims for nonreceipt of issues will be honored if made within three months of publication of the issue. All issues are dispatched by airmail throughout
the world, excluding the USA and Canada.
2015
NPC Natural Product Communications Vol. 10
No. 6
Anti-inflammatory Flavonoids Isolated from Passiflora foetida 929 - 931
Thi Yen Nguyena, Dao Cuong Toa, Manh Hung Trana, Joo Sang Leea, Jeong Hyung Leeb, Jeong Ah Kimc*,
Mi Hee Wooa and Byung Sun Mina*
a
College of Pharmacy, Drug Research and Development Center, Catholic University of Daegu,
Gyeongsan 712–702, Korea
b
College of Natural Sciences, Kangwon National University, Gangwon-Do 200-701, Korea
c
College of Pharmacy, Research Institute of Pharmaceutical Sciences, Kyungpook National University, Daegu,
702-701 Korea
In this study, we evaluated the anti-inflammatory activity of the soluble ethyl acetate fraction and chemical components of the stem bark of Passiflora foetida
(Passifloraceae). Ten flavonoids (1―10) were isolated by various chromatographic techniques, and their structures were determined based on spectroscopic
analyses by using nuclear magnetic resonance (NMR). Luteolin (2) and chrysoeriol (3) showed the most potent inhibition of nitric oxide (NO) production in
macrophage cell line, RAW264.7, with half maximal inhibitor concentration (IC50) values of 1.2 and 3.1 μM, respectively. These compounds suppressed
lipopolysaccharide (LPS)-induced inducible NO synthase (iNOS) expression at the transcription level. Our research indicates that the stem bark of P. foetida
has significant anti-inflammatory properties, suggesting that its flavonoids may have anti-inflammatory benefits.
Inflammation is a protective response that occurs following trauma, studies have reported that the aqueous and organic extracts of P.
infection, tissue injury, or noxious stimuli [1a]. In this process, foetida leaves and fruits have numerous biological effects, including
activated inflammatory cells, including neutrophils, eosinophils, antibacterial, antioxidant, and anti-inflammatory activities and can
mononuclear phagocytes, and macrophages, secrete increased be applied to treat various symptoms, such as hysteria, insomnia,
amounts of nitric oxide (NO), prostaglandin E2 (PGE2), and headaches, and asthma [2b-2e]. However, the anti-inflammatory
cytokines such as interleukin (IL)-1β, IL-6, and tumor necrosis effects of the stem bark constituents remain unclear. Thus, we
factor (TNF)-α. These substances not only induce cell and tissue describe the physical chemistry of the isolates and their isolation,
damage but also activate macrophages in other diseases, including and evaluated their effect on inflammation. The stem bark
rheumatoid arthritis and chronic hepatitis [1b]. In particular, a methanolic (MeOH) extract of P. foetida was partitioned into n-
growing body of evidence suggests that chronic inflammation can hexane-, chloroform (CHCl3-), ethyl acetate (EtOAc)-, n-BuOH (n-
lead to cancer [1c]. NO is a major inflammatory byproduct, and its butanol-), and water-soluble fractions. In a preliminary experiment,
production is controlled by nitric oxide synthases (NOS), which the anti-inflammatory effects of these fractions were evaluated by
include inducible NOS (iNOS), endothelial NOS (eNOS), and using varying concentrations (0-30 μg/mL). The EtOAc fraction
neuronal NOS (nNOS). Importantly, iNOS is highly expressed in showed the greatest inhibitory activity and was selected for further
macrophages, and its activation leads to organ destruction in some isolation of the active components by bioactivity-guided
inflammatory and autoimmune diseases [1d]. During inflammation, fractionation. Chromatographic purification of the EtOAc fraction
macrophages play a central role in managing many immune- led to the isolation of ten compounds (1―10) (Figure 1).
pathological phenomena, including the overproduction of pro-
inflammatory cytokines and inflammatory mediators, such as IL-1β,
IL-6, NO, iNOS, cyclooxygenase (COX)-2, and TNF-α. Indeed, a
number of inflammatory stimuli, such as lipopolysaccharide (LPS)
and pro-inflammatory cytokines, activate immune cells to
upregulate such inflammatory states. The overproduction of NO by
iNOS has been implicated in the pathology of several inflammatory
disorders, including septic shock, tissue damage after inflammation,
and rheumatoid arthritis [1e-1g]. Thus, LPS-induced, iNOS-
mediated NO production may reflect the degree of inflammation,
and changes in NO levels through the inhibition of iNOS activity
could represent a novel method to assess the anti-inflammatory
effects of novel compounds.
The structures of these compounds were determined to be apigenin hydroxyl substitutions on the A- and B-ring influence the inhibitory
(1), luteolin (2), chrysoeriol (3), tricin (4), quercetin-4'-methyl ether activity. A-ring 5-/7- and B-ring 3-/4-hydroxylation(s) gave
(5), vitexin (6), vitexin-2"-O-xyloside (7), orientin (8), apigenin 7- favorable results, while C-3 hydroxylation (flavonol) did not. We
O-β-D-glucopyranoside (9), and luteolin 7-O-β-D-glucopyranoside also demonstrated that the active flavonoids did not significantly
(10) by comparing their physical and spectroscopic data with inhibit iNOS activity [4b]. These findings were consistent with a
previous data [2f-2l]. study that showed luteolin, apigenin, and chrysoeriol inhibited NO
production via iNOS down-regulation [4c]. Flavanone derivatives,
The cytotoxic effects of the isolated compounds (1―10) were which do not have a C-2,3 double bond, were inactive up to 30 µM.
evaluated by {3-(4,5-dimethylthaizol-2-yl)-2-5-diphenyltetrazolium These results indicated that a planar ring system in the flavonoid
bromide (MTT)} assay. The compounds did not affect the viability molecule is important for NO inhibition [4d]. Following these
of RAW 264.7 macrophage cells after 24 h treatment in either the investigations, many researchers reported similar properties of
presence or absence of LPS, even at a dose of 30 μM (data not various flavonoids. They included flavones such as apigenin and
shown). In RAW 264.7 cells, LPS stimulation can induce iNOS oroxylin A, flavonols such as kaempferol and quercetin,
transcription and protein synthesis and subsequent NO production bioflavonoids such as bilobetin and ginkgetin, and some prenylated
[3a]. Therefore this cell system is an excellent model to evaluate flavonoids, including sanggenons and kuwanon C. Interestingly,
topical agents and screen potential inhibitors of the iNOS pathway some prenylated flavonoids inhibited LPS-induced NO production
and NO production [3b]. To evaluate the effect of compounds in RAW 264.7 cells by inducing cytotoxicity, because prenylated
1―10 on NO production, the Griess assay was performed [3c]. As flavonoids were toxic at doses higher than 50 mM [4e]. Thus, it is
shown in Table 1, compounds 1―3 inhibited NO production, with possible that the inhibition of NO production by these flavonoids
half maximal inhibitor concentration (IC50) values of 6.5, 1.2, and may be due, in part, to their reduction of iNOS expression. In
3.1 μM, respectively. Compound 4 had a moderate effect on NO conclusion, certain flavonoids, especially flavones such as luteolin,
production, with an IC50 value of 28.0 μM; however, the other inhibited NO production in LPS-stimulated RAW 264.7 cells in
compounds were inactive. vitro. Inhibition of NO production may contribute to the anti-
inflammatory and immunoregulatory activity of flavonoids.
Table 1: Inhibition of NO production in macrophage RAW264.7 cells by compounds
1-10.
Experimental
Compds IC50, μMa Compds IC50, μMa
1 6.5 ± 0.9 7 > 30 Plant material: The stem bark of P. foetida was collected in
2 1.2 ± 0.2 8 > 30 November, 2011 in Cao Bang province, Northern Vietnam. The
3 3.1 ± 0.5 9 > 30 sample was authenticated by Professor Vu Xuan Phuong, and the
4 28.0 ± 3.0 10 > 30
5 > 30 Celastrolb 1.0 ± 0.1 voucher specimen was deposited at the Herbarium of the Institute of
6 > 30 Ecology and Biological Resources, Vietnam Academy of Science
a
50% inhibition concentrations are expressed as the mean ±S.E.M. of triple and Technology.
experiments; bPositive control.
Extraction and isolation: The stem bark of P. foetida (4.0 kg) was
Western blot analysis was performed to determine the inhibitory
extracted by refluxing with methanol (3 times × 3 L). After the
effects of compounds 2 and 3 on iNOS expression. These
solvent was removed under reduced pressure, the residue was
compounds (0–10 μM) dose-dependently reduced LPS-induced
suspended in water and partitioned with n-hexane, CHCl3, EtOAc,
iNOS expression, but did not alter α-tubulin expression, suggesting
and n-BuOH, successively. Using activity-guided fractionation, the
that compounds 2 and 3 inhibited iNOS activity in LPS-stimulated
EtOAc soluble fraction (17.0 g) was resolved by silica gel column
RAW264.7 cells (Figure 2).
chromatography (CC), eluting with a gradient of CHCl3-MeOH
(30:1→1:1), to obtain 14 fractions (Fr.E1-E14). Compound 5 was
obtained as crystals in methanol by collecting the EtOAc soluble
fraction. Fraction E3 (204.7 mg) was subjected to RP-C18 silica gel
CC and eluted with MeOH-H2O (1:3→9:1) to afford 10 sub-
fractions (Fr.E3-1-E3-10). Further purification of Fr.E3-8 (170 mg)
by using Sephadex LH-20 silica gel CC and eluting with MeOH-
H2O (2:1→4:1) yielded compounds 3 (5.6 mg) and 4 (6.1 mg).
Figure 2: Inhibition of LPS-induced iNOS expression in RAW 264.7 cells by From fraction E4 (510.6 mg), 7 sub-fractions (Fr.E4-1~E4-7) were
compounds 2 and 3. obtained by using C-18 silica gel CC with gradient MeOH-H2O
(1:3→1:2) elution. Further purification of E4-7 (80 mg) by
While a small amount of NO synthesized by eNOS and nNOS is Sephadex LH-20 gel CC eluted with MeOH-H2O (1:1→3:1)
essential for maintaining homeostasis, the significantly higher resulted in compound 2 (13.0 mg). Sub-fraction E4-5 (46.7 mg)
amount of NO synthesized by iNOS synergistically promotes underwent medium pressure liquid chromatography (MPLC) on an
inflammatory processes in conjunction with other inflammatory octadecyl silica (ODS) gel column chromatograph by using a
mediators [4a]. Thus, the inhibition of iNOS activity or gradient of MeOH-H2O (1:3→1:1) to obtain compound 10 (4.5
downregulation of iNOS expression could be beneficial to inhibit mg). From fraction E5 (3.5 g), 14 sub-fractions (Fr. E5-1-E5-14)
inflammatory responses. Based on these results, flavonoid were obtained after RP–C18 silica gel CC and elution with MeOH-
glycosides (5―10) did not significantly inhibit NO production at 30 H2O (1:4→1:1). Compound 1 (6.0 mg) was obtained by purifying
µM, regardless of the aglycones (flavone, flavonol) present and the sub-fraction E5-14 (40.0 mg) by using Sephadex LH-20 gel CC
glycoside linkages (C- or O-glycosides). Some flavones/flavonols, eluted with MeOH-H2O (1:2→2:1). Fraction E6 (1.01 g) was
mainly flavones (1―4), significantly inhibited NO production. In subjected to silica gel CC and elution with a gradient of n-hexane-
general, flavones showed stronger inhibition of NO production than acetone (7:1→3:5), yielding 3 sub-fractions (Fr.E6-1-E6-3). Sub-
flavonols (Table 1). Luteolin (2) was the most active inhibitor fraction E6-1 (196 mg) underwent MPLC by using an Ultra pack,
among the flavonoids tested. These results strongly suggest that the ODS-S-50A column. Using a mobile phase consisting of methanol
C-2,3 double bond is crucial for inhibiting NO production, and the
Anti-inflammatory activity flavonoids from Passiflora foetida Natural Product Communications Vol. 10 (6) 2015 931
in water (1:3→3:2), compounds 8 (13.2 mg) and 9 (7.2 mg) were Immunoblot analysis: Proteins were extracted from cells in ice-
obtained. Fraction E7 (153.8 g) was subjected to silica gel cc and cold lysis buffer (50 mM Tris-HCl, pH 7.5, 1% Nonidet P-40, 1
eluted with CH2Cl2-EtOAc-H+ (9:1:0.05→1:1: 0.05) to obtain 9 mM ethylenediaminetetraacetic acid, EDTA; 1 mM
sub-fractions (Fr. E7.1~E7.9). Compounds 6 (4.5 mg, tR = 30.5 phenylmethylsulfonyl fluoride, 1 μg/mL leupeptin, 1 mM sodium
min) and 7 (8.7 mg, tR = 39.8 min) were obtained from sub-fraction vanadate, and 150 mM sodium chloride, NaCl). Proteins (50 μg)
E7.1 (85 mg) by semi-preparative HPLC, by using a gradient of were loaded to each lane for separation by sodium dodecyl sulfate-
acetonitrile (ACN)-H2O (15:85→25: 75) over 60 min, a flow rate of polyacrylamide gel electrophoresis and transferred to a
5 mL/min, UV detection at 280 and 330 nm, and a YMC-pack- polyvinylidene difluoride membrane (Millipore, Bedford, MA,
ODS-A column (20 × 250 mm, 5 µm). USA). The membrane was blocked with 5% skim milk and then
incubated with the corresponding antibody. The antibody for iNOS
Determination of NO production and cell viability: The level of was obtained from Santa Cruz Biotechnology (Santa Cruz, CA,
NO production was determined by measuring the amount of nitrite USA). The antibody for α-tubulin was obtained from Sigma. After
present in the cell culture supernatants, as described previously [3c]. binding of an appropriate secondary antibody coupled to
Briefly, RAW 264.7 cells (1 × 105 cells/well) were stimulated in the horseradish peroxidase, proteins were visualized by enhanced
presence or absence of 1 μg/mL LPS (Sigma Chemical Co.; St. chemiluminescence according to the manufacturer’s instructions
Louis, MO, USA) for 24 h, with or without the test compounds (Amersham Pharmacia Biotec; Buckinghamshire, UK) [3c].
(0.5−30 μM). The cell culture supernatant (100 μL) was then
reacted with 100 μL Griess reagent (1% sulfanilamide in 5% Statistical analysis: Values are expressed as mean ± S.E.M.
phosphoric acid and 0.1% naphthylethylenediamine dihydrochloride
in distilled H2O). The absorbance at 540 nm was determined by Acknowledgments - This research was supported by the Basic
microplate reader (Molecular Devices, Emax, Sunnyvale, CA, Science Research Program through the National Research
USA), and the absorption coefficient was calibrated by using a Foundation of Korea (NRF) funded by the Ministry of Science, ICT
sodium nitrite (NaNO2) solution standard. Cell viability was & Future Planning (KRF-2012R1A2A2A06046921, KRF-
measured with the MTT-based colorimetric assay. For this 2012R1A1A2003547, and NRF-2013R1A1A1008086). We are
experiment, celastrol was used as a positive control [3c]. grateful to the Korean Basic Science Institute (KBSI) for supplying
the NMR spectra.
References
[1] (a) Zedler S, Faist E. (2006) The impact of endogenous triggers on trauma-associated inflammation. Current Opinion in Critical Care, 12, 595–
601; (b) Vane JR, Mitchell JA, Appleton I, Tomlinson A, Bishop-Bailey D, Croxtall J, Willoughby DA. (1994) Inducible isoforms of
cyclooxygenase and nitric oxide synthase in inflammation. Proceedings of the National Academy Sciences, 91, 2046–2050; (c) Schottenfild D,
Beebe-Dimmer J. (2006) Chronic inflammation: A common and important factor in the pathogenesis of neoplasia. A Cancer Journal for Clinicians,
56, 69–83; (d) Murakami A, Ohigashi H. (2007) Targeting NOX, iNOS and COX-2 in inflammatory cells: chemoprevention using food
phytochemicals. International Journal of Cancer, 121, 2357–2363; (e) Farrell AJ, Blake DR, Palmer RM, Moncada S. (1992) Increased
concentrations of nitrite in synovial fluid and serum samples suggest increased nitric oxide synthesis in rheumatic diseases. Annals of the Rheumatic
Diseases, 51, 1219–1222; (f) Kilbourn RG, Jubran A, Gross SS, Griffith OW, Levi R, Adams J, Lodato RF. (1990) Reversal of endotoxin-mediated
shock by NG-methyl-L-arginine, an inhibitor of nitric oxide synthesis. Biochemical and Biophysical Research Communication, 172, 1132–1138;
(g) Kroncke KD, Fehsel K, Kolb-Bachofen V. (1998) Inducible nitric oxide synthase in human disease. Clinical & Experimental Immunology, 113,
147–156.
[2] (a) Felter HW, Lyod JU. (1898) King’s American Dispensatory. Eclectic Medical Publications; (b) Mohansundari C, Natarajan D, Srinivasan K,
Umamaheshwari S, Ramchandran A. (2007) Antibacterial properties of Passiflora foetida L. – a common exotic medicinal plant. African Journal of
Biotechnology, 6, 2650–2653; (c) Rasool SN, Jaheerunisa S, Jayveera KN, Suresh-Kumar C. (2011) In vitro callus induction and in vivo antioxidant
activity of Passiflora foetida L. leaves. International Journal of Applied Research in Natural Products, 4, 1–10; (d) Nwosu MO. (1999) Herbs for
mental disorders. Fitoterapia, 70, 58–63; (e) Chopra RN, Badhwar RL, Ghosh S. (1944) Poisonous Plants of India. Public Service Commission,
Government of West Bengal, Calcutta, India, 469–472; (f) Agrawal PK. (1989) Carbon-13 NMR of flavonoids. Elsevier, Amsterdam, The
Neetherlands, 127; (g) Amani, Awaad S, Maitland DJ, Soliman GA, (2006) Hepatoprotective activity of Schouwia thebica webb. Bioorganic &
Medicinal Chemistry Letters, 16, 4624–4628; (h) Chang CL, Wang GJ, Zhang LJ, Tsai WJ, Chen RY, Wua YC, Kuo YH. (2010) Cardiovascular
protective flavonolignans and flavonoids from Calamus quiquesetinervius. Phytochemistry, 71, 271–279; (i) Ezenyi IC, Salawu OA, Kulkarni R,
Emeje M. (2014) Antiplasmodial activity-aided isolation and identification of quercetin-4'-methyl ether in Chromolaena odorata leaf fraction with
high activity against chloroquine-resistant Plasmodium falciparum. Parasitology Research, 113, 4415–4422; (j) Choo CY, Sulong NY, Mana F,
Wong TW. (2012) Vitexin and isovitexin from the leaves of Ficus deltoidea with in vivo α-glucosidase inhibition. Journal of Ethnopharmacology,
142, 776–781; (k) Faiella L, Temraz A, De Tommasi N, Braca A. (2012) Diterpenes, ionol-derived, and flavone glycosides from Podocarpus
elongatus. Phytochemistry, 76, 172–177; (l) Mohammed RS, Abou Zeid AH, El Hawary SS, Sleem AA, Ashour WE. (2014) Flavonoid
constituents, cytotoxic and antioxidant activities of Gleditsia triacanthos L. leaves. Saudi Journal of Biological Sciences,
doi:10.1016/j.sjbs.2014.02.002.
[3] (a) Park EJ, Cheenpracha S, Chang LC, Kondratyuk TP, Pezzuto JM. (2011) Inhibition of lipopolysaccharide-induced cyclooxygenase-2 expression
and inducible nitric oxide synthase by 4-[(2′-O-acetyl-α-L-rhamnosyloxy)benzyl] isothiocyanate from Moringa oleifera. Nutrition and Cancer, 63,
971–982; (b) Ahn KS, Noh EJ, Zhao HL, Jung SH, Kang SS, Kim YS. (2005) Inhibition of inducible nitric oxide synthase and cyclooxygenase II
by Platycodon grandiflorum saponins via suppression of nuclear factor-κB activation in RAW 264.7 cells. Life Sciences, 76, 2315–2328; (c) Lee J,
Tae N, Lee JJ, Kim T, Lee JH. (2010) Eupatolide inhibits lipopolysaccharide-induced COX-2 and iNOS expression in RAW264.7 cells by inducing
proteasomal degradation of TRAF6. European Journal of Pharmacology, 636, 173-180.
[4] (a) Nathan C. (1992) Nitric oxide as a secretory product of mammalian cells. The FASEB Journal, 6, 3051–3064; (b) Kim HP, Son KH, Chang HW,
Kang SS. (2004) Anti-inflammatory plant flavonoids and cellular action mechanism. Journal of Pharmacological Sciences, 96, 229–245; (c) Liang
YC, Huang YT, Tsai SH, Lin-Shiau Y, Chen CF, Lin JK. (1999) Suppression of inducible cyclooxygenase and inducible nitric oxide synthase by
apigenin and related flavonoids in mouse macrophages. Carcinogenesis, 20, 1945–1952; (d) Kim HK, Cheon BS, Kim YH, Kim SY, Kim HP.
(1999) Effects of naturally occurring flavonoids on nitric oxide production in the macrophage cell line RAW 264.7 and their structure-activity
relationships. Biochemical Pharmacology, 58, 759–765; (e) Cheon BS, Kim YH, Son KH, Chang HW, Kang SS, Kim HP. (2000) Effects of
prenylated flavonoids and biflavonoids on lipopolysaccharide-induced nitric oxide production from the mouse macrophage cell line, RAW 264.7.
Planta Medica, 66, 596–600.
Natural Product Communications Vol. 10 (6) 2015
Published online (www.naturalproduct.us)
Accounts/Reivews
Recent Advances in the Synthesis of Stemona Alkaloids
Xiao-Yu Liu and Feng-Peng Wang 1093
Flavonoid Properties in Plant Families Synthesizing Betalain Pigments (Review)
Tsukasa Iwashina 1103
Phytochemistry and Pharmacology of the Genus Tovomita
Francesco Epifano, Maria Carmela Specchiulli, Vito Alessandro Taddeo, Serena Fiorito and Salvatore Genovese 1115
Fungal Phytotoxins with Potential Herbicidal Activity to Control Chenopodium album
Alessio Cimmino, Marco Masi, Marco Evidente and Antonio Evidente 1119
Essential Oils as “A Cry for Help”. A Review
Christine Zitzelsberger and Gerhard Buchbauer 1127
Natural Product Communications Vol. 10 (6) 2015
Published online (www.naturalproduct.us)
Preface iii
Original Paper